Advertisement

Index by Author

April 2000; 23 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ackerson, L M

    • Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care April 2000 23:477-483; doi:10.2337/diacare.23.4.477

  2. Addy, C L

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  3. Ahluwalia, H K

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  4. Ahluwalia, J S

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  5. Ainsworth, B E

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

B

  1. Bangstad, H J

    • Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care April 2000 23:544-548; doi:10.2337/diacare.23.4.544

  2. Basaria, S

    • Link between diabetes and osteoporosis. Diabetes Care April 2000 23:564-565; doi:10.2337/diacare.23.4.564

  3. Baudouy, M

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  4. Bayer, T

    • Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes. Diabetes Care April 2000 23:518-523; doi:10.2337/diacare.23.4.518

  5. Becker, D

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  6. Beckles, G L

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  7. Bertolini, L

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

  8. Bloomgarden, Z T

    • American Diabetes Association annual meeting, 1999: nephropathy and neuropathy. Diabetes Care April 2000 23:549-556; doi:10.2337/diacare.23.4.549

  9. Boyko, E J

    • Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care April 2000 23:465-471; doi:10.2337/diacare.23.4.465

  10. Byrne, H A

    • Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care April 2000 23:500-503; doi:10.2337/diacare.23.4.500

C

  1. Caballero, S

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

  2. Cacciatori, V

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

  3. Calvert, G D

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  4. Campbell, L V

    • Increasing incidence of type 2 diabetes in the third millennium: is abdominal fat the central issue? Diabetes Care April 2000 23:441-442; doi:10.2337/diacare.23.4.441

  5. Canivet, B

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  6. Castillo-Ros, S

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  7. Clarke, C F

    • Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care April 2000 23:533-538; doi:10.2337/diacare.23.4.533

  8. Cooper-DeHoff, R

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

  9. Cronmiller, N

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

D

  1. Daimon, M

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  2. Darbinian, J A

    • Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care April 2000 23:477-483; doi:10.2337/diacare.23.4.477

  3. Dornan, T L

    • Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care April 2000 23:500-503; doi:10.2337/diacare.23.4.500

  4. Drash, A L

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  5. Dunger, D B

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  6. Durstine, J L

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  7. Dyck, P J

    • Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care April 2000 23:510-517; doi:10.2337/diacare.23.4.510

E

  1. Edge, J A

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  2. Eguchi, H

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  3. Elkeles, R S

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  4. Estes, K S

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

F

  1. Faccini, G

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

  2. Feher, M D

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  3. Feldman, H A

    • Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care April 2000 23:490-494; doi:10.2337/diacare.23.4.490

  4. Ferrara, A

    • Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care April 2000 23:477-483; doi:10.2337/diacare.23.4.477

  5. Fitzgerald, C

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

  6. Fredenrich, A

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  7. Fruhstorfer, H

    • Capillary blood volume and pain intensity depend on lancet penetration. Diabetes Care April 2000 23:562-563; doi:10.2337/diacare.23.4.562

  8. Fujimoto, W Y

    • Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care April 2000 23:465-471; doi:10.2337/diacare.23.4.465

G

  1. Gebhart, S S

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  2. Gedroyc, W M

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  3. Goldfracht, M

    • Nationwide program for improving the care of diabetic patients in Israeli primary care centers. Diabetes Care April 2000 23:495-499; doi:10.2337/diacare.23.4.495

  4. Grant, M B

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

H

  1. Hamdy, O

    • Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care April 2000 23:490-494; doi:10.2337/diacare.23.4.490

  2. Hamilton, P

    • Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care April 2000 23:455-459; doi:10.2337/diacare.23.4.455

  3. Harter, M

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  4. Hazariwala, K M

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

  5. Heine, R J

    • Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care April 2000 23:529-532; doi:10.2337/diacare.23.4.529

  6. Henzen, C

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  7. Hieronimus, S

    • Screening for silent myocardial ischemia in diabetic patients. Diabetes Care April 2000 23:563-564; doi:10.2337/diacare.23.4.563

  8. Hirata, A

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  9. Hollis, S

    • Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care April 2000 23:500-503; doi:10.2337/diacare.23.4.500

  10. Horton, E S

    • Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care April 2000 23:490-494; doi:10.2337/diacare.23.4.490

I

  1. Igarashi, M

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  2. Irwin, M L

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  3. Ismail, I

    • Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes. Diabetes Care April 2000 23:518-523; doi:10.2337/diacare.23.4.518

J

  1. Janssen, M M

    • Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care April 2000 23:529-532; doi:10.2337/diacare.23.4.529

  2. Jenkins, A B

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  3. Jenkins, E J

    • Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care April 2000 23:455-459; doi:10.2337/diacare.23.4.455

  4. Jin, Y

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  5. Johannesen, J

    • CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care April 2000 23:560-562; doi:10.2337/diacare.23.4.560

K

  1. Karter, A J

    • Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care April 2000 23:477-483; doi:10.2337/diacare.23.4.477

  2. Kato, T

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  3. Kelsey, S F

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  4. Kerr, D

    • Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care April 2000 23:455-459; doi:10.2337/diacare.23.4.455

  5. King, A B

    • A comparison in a clinical setting of the efficacy and side effects of three thiazolidinediones. Diabetes Care April 2000 23:557; doi:10.2337/diacare.23.4.557b

  6. Kong, C

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

L

  1. Lafferty, A R

    • Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care April 2000 23:533-538; doi:10.2337/diacare.23.4.533

  2. Lang, A M

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  3. Larson, T S

    • Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care April 2000 23:510-517; doi:10.2337/diacare.23.4.510

  4. Leonetti, D L

    • Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care April 2000 23:465-471; doi:10.2337/diacare.23.4.465

  5. Lunt, M J

    • Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care April 2000 23:455-459; doi:10.2337/diacare.23.4.455

  6. Luzio, S D

    • Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes. Diabetes Care April 2000 23:518-523; doi:10.2337/diacare.23.4.518

M

  1. Mames, R N

    • The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care April 2000 23:504-509; doi:10.2337/diacare.23.4.504

  2. Manaka, H

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  3. Mayer-Davis, E J

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  4. Mayo, M S

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  5. McKinlay, J B

    • Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care April 2000 23:490-494; doi:10.2337/diacare.23.4.490

  6. Miller, C D

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  7. Miller, C E

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  8. Mohn, A

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  9. Moses, R G

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  10. Muggeo, M

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

N

  1. Nerup, J

    • CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care April 2000 23:560-562; doi:10.2337/diacare.23.4.560

  2. Newell-Morris, L

    • Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care April 2000 23:465-471; doi:10.2337/diacare.23.4.465

  3. New, J P

    • Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care April 2000 23:500-503; doi:10.2337/diacare.23.4.500

O

  1. O'Brien, P C

    • Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care April 2000 23:510-517; doi:10.2337/diacare.23.4.510

  2. Ohnuma, H

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  3. Orchard, T J

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  4. Osterby, R

    • Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care April 2000 23:544-548; doi:10.2337/diacare.23.4.544

  5. Owens, D R

    • Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes. Diabetes Care April 2000 23:518-523; doi:10.2337/diacare.23.4.518

P

  1. Pan, J F

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  2. Parving, H H

    • CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care April 2000 23:560-562; doi:10.2337/diacare.23.4.560

  3. Pate, R R

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  4. Phillips, L S

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  5. Pickard, S P

    • Prevalence and correlates of preventive care among adults with diabetes in Kansas. Diabetes Care April 2000 23:484-489; doi:10.2337/diacare.23.4.484

  6. Pociot, F

    • CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care April 2000 23:560-562; doi:10.2337/diacare.23.4.560

  7. Porath, A

    • Nationwide program for improving the care of diabetic patients in Israeli primary care centers. Diabetes Care April 2000 23:495-499; doi:10.2337/diacare.23.4.495

  8. Porwoll, J M

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  9. Poulter, C

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

R

  1. Rasmussen, L M

    • Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care April 2000 23:544-548; doi:10.2337/diacare.23.4.544

  2. Robinson, A C

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  3. Robinson, S

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  4. Rossman, S D

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  5. Rudberg, S

    • Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria. Diabetes Care April 2000 23:544-548; doi:10.2337/diacare.23.4.544

S

  1. Saitoh, T

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

  2. Samaras, K

    • Increasing incidence of type 2 diabetes in the third millennium: is abdominal fat the central issue? Diabetes Care April 2000 23:441-442; doi:10.2337/diacare.23.4.441

  3. Schmelzeisen-Redeker, G

    • Capillary blood volume and pain intensity depend on lancet penetration. Diabetes Care April 2000 23:562-563; doi:10.2337/diacare.23.4.562

  4. Selby, J V

    • Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care April 2000 23:477-483; doi:10.2337/diacare.23.4.477

  5. Shao, Y F

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  6. Shi, H L

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  7. Snoek, F J

    • Assessing impaired hypoglycemia awareness in type 1 diabetes: agreement of self-report but not of field study data with the autonomic symptom threshold during experimental hypoglycemia. Diabetes Care April 2000 23:529-532; doi:10.2337/diacare.23.4.529

  8. Songer, T J

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  9. Stellato, R K

    • Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care April 2000 23:490-494; doi:10.2337/diacare.23.4.490

  10. Stolarczyk, L M

    • Moderate-intensity physical activity and fasting insulin levels in women: the Cross-Cultural Activity Participation Study. Diabetes Care April 2000 23:449-454; doi:10.2337/diacare.23.4.449

  11. Storlien, L H

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  12. Strang, S

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  13. Sugiyama, K

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

T

  1. Tapsell, L C

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  2. Targher, G

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

  3. Tarnow, L

    • CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients. Diabetes Care April 2000 23:560-562; doi:10.2337/diacare.23.4.560

  4. Tate, M K

    • Meeting American Diabetes Association guidelines in endocrinologist practice. Diabetes Care April 2000 23:444-448; doi:10.2337/diacare.23.4.444

  5. Tieszen, K L

    • Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care April 2000 23:500-503; doi:10.2337/diacare.23.4.500

V

  1. Valabhji, J

    • Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care April 2000 23:539-543; doi:10.2337/diacare.23.4.539

  2. Velosa, J A

    • Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care April 2000 23:510-517; doi:10.2337/diacare.23.4.510

W

  1. Wang, Y

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  2. Watson, J M

    • Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care April 2000 23:455-459; doi:10.2337/diacare.23.4.455

  3. Weissfeld, J

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  4. Weiss, T

    • Capillary blood volume and pain intensity depend on lancet penetration. Diabetes Care April 2000 23:562-563; doi:10.2337/diacare.23.4.562

  5. Wernicke-Panten, K

    • Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen. Diabetes Care April 2000 23:557-559; doi:10.2337/diacare.23.4.557a

  6. Werther, G A

    • Ambulatory blood pressure, microalbuminuria, and autonomic neuropathy in adolescents with type 1 diabetes. Diabetes Care April 2000 23:533-538; doi:10.2337/diacare.23.4.533

Y

  1. Yamaguchi, H

    • Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes. Diabetes Care April 2000 23:559-560; doi:10.2337/diacare.23.4.559

Z

  1. Zenari, L

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

  2. Zgibor, J C

    • The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care April 2000 23:472-476; doi:10.2337/diacare.23.4.472

  3. Zhu, X X

    • Dietary variables and glucose tolerance in pregnancy. Diabetes Care April 2000 23:460-464; doi:10.2337/diacare.23.4.460

  4. Zoppini, G

    • Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care April 2000 23:524-528; doi:10.2337/diacare.23.4.524

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement